Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Dana-Farber Cancer Institute
Sponsor:
Collaborator:
National Comprehensive Cancer Network
Information provided by (Responsible Party):
Danielle Margalit, MD, MPH, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01783587
First received: January 30, 2013
Last updated: July 14, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2018
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)